Chris was invited to speak at the ACI Paragraph IV Disputes Master Symposium on October 2-3, 2017 in Chicago.
This annual event brings together patent litigators, leading in-house counsel and members of the judiciary to provide insight on the latest developments concerning Paragraph IV (Hatch-Waxman) litigation. As a panelist, Chris provided the attendees with an update and observations on recent developments relating to the issue of induced infringement in the pharma context.
